AZ Q2 Preview: Pipeline, COVID-19 and M&A Key Focus

Oncology Drugs Will Be Growth Drivers

 
• By Sten Stovall

AstraZeneca’s half-year results, out on 30 July, will be keenly watched due to the pharma’s attractive near-term growth, pipeline catalysts and its promising COVID-19 vaccine. 

AZ
AZ’s pipeline is emerging as one of the strongest in the pharma sector • Source: Shutterstock

More from Earnings

More from Business